Market Research Industry Reports

2018 Japan Microbiology Analyzers and Reagents Market: Supplier Shares and Sales Segment Forecasts by Product: Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS

Complete report $8,800.  DataPack (test volumes, sales forecasts, supplier shares) $5,700.

new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies. 

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, Hepatitis, H. Pylori, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Geographic Coverage

France, Germany, Italy, Spain, UK

Market Segmentation Analysis

- Sales and market shares of major suppliers by individual test and country.

- Volume and sales forecasts for over 100 infectious disease assays by country, individual test and market segment:

      ° Hospitals
      ° Blood Banks
      ° Commercial/Private Laboratories
      ° Public Health Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

- Review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Current and Emerging Products

- In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing.

- Global listings of companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Contains 976 pages and 160 tables

I. Introduction
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests

1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakobs Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori

33. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus
56. Rubella
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina


B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semiautomated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
VIII. Japan Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
IX. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem

- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables

List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests

Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests

Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
Japan Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Laboratories Performing Infectious Disease Tests
by Market Segment
Japan
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
Japan
Commercial/Private Laboratories Performing
Infectious Disease Tests by Annual Test Volume
Japan
All Market Segments Infectious Disease Test Volume Forecast
Japan
All Market Segments Infectious Disease Test Volume by Method

Japan
Hospital Laboratories Infectious Disease Test
Volume Forecast
Japan
Blood Banks Infectious Disease Test Volume Forecast
Japan
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
Japan
All Market Segments Infectious Disease Diagnostics
Market Forecast
Japan
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
Japan
Blood Banks Infectious Disease Diagnostics Market Forecast
Japan
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
Japan
HIV or HIV I/HIV II/Combo Test Volume and Diagnostics Sales
by Market Segment Forecast
Japan
HIVAg Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan
Adenovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Aeromonads Test Volume and Diagnostics Sales Forecast by
Market Segment

Japan
BEA Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Blastocystis Hominis Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Campylobacter Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Candida Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Japan
Chlamydia Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Clostridium Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Coronavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
CoxsackieVirus Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Cryptosporidium Test Volume and Diagnostics Sales
Forecast by Market Segment

Japan
Cyclospora Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
CMV Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
E. Coli Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Echovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Encephalitis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Enterovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
EBV Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Giardia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Granuloma Inguinale Test Volume and Diagnostics
Sales Forecast by Market Segment

Japan
HantaVirus Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Helicobacter Pylori Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
HAV NAT Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
HBV NAT Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
HBsAg Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
HCV Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
HCV NAT Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Hepatitis C Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Anti-HBc Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Anti-HBs Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Anti-HAV Test Volume and Diagnostics Sales Forecast
by Market Segment

Japan
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
HBcAg Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
HBeAg Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Influenza Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Legionella Test Volume and Diagnostics Sales Forecast by
Market Segment
Japan
Lyme Disease Test Volume and Diagnostics Sales Forecast by
Market Segment

Japan
Lymphogranuloma Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Malaria Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Measles Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Meningitis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Microsporidium Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Mononucleosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Mumps Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Mycoplasma Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Papilloma Virus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Parvovirus Test Volume and Diagnostics Sales Forecast
by Market Segment

Japan
Pneumonia Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Polyomaviruses Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Pseudomonas Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Rabies Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
RSV Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Rhinovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Rotavirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Rubella Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Salmonella Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Septicemia Test Volume and Diagnostics Sales Forecast
by Market Segment

Japan
Shigella Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Staphylococci Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan
Streptococci Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Syphilis Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Trichomonas Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Tuberculosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Vibrio Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
West Nile Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
Yersinia Test Volume and Diagnostics Sales Forecast by Market
Segment

Japan
AIDS Testing Market Diagnostics Sales by Major
Supplier
Japan
Campylobacter Testing Market Diagnostics Sales by Major
Supplier
Japan
Candida Testing Market Diagnostics Sales by Major
Supplier
Japan
Chlamydia Testing Market Diagnostics Sales by Major
Supplier
Japan
CMV Testing Market Diagnostics Sales by Major
Supplier
Japan
Gonorrhea Testing Market Diagnostics Sales by Major
Supplier
Japan
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
Japan
Hepatitis C Testing Market Diagnostics Sales by Major
Supplier
Japan
Herpes Testing Market Diagnostics Sales by Major
Supplier
Japan
Legionella Testing Market Diagnostics Sales Forecast by Major
Supplier

Japan
Meningitis Testing Market Diagnostics Sales by Major
Supplier
Japan
Mononucleosis Testing Market Diagnostics Sales
by Major Supplier
Japan
Mycoplasma Testing Market Diagnostics Sales by Major
Supplier
Japan
Pneumonia Testing Market Diagnostics Sales by Major
Supplier
Japan
RSV Testing Market Diagnostics Sales by Major Supplier
Japan
Rotavirus Testing Market Diagnostics Sales by Major
Supplier
Japan
Rubella Testing Market Diagnostics Sales by Major
Supplier
Japan
Septicemia Testing Market Diagnostics Sales by Major
Supplier
Japan
Shigella Testing Market Diagnostics Sales by Major
Supplier
Japan
Streptococci Testing Market Diagnostics Sales by
Major Supplier

Japan
Syphilis Testing Market Diagnostics Sales by Major
Supplier
Japan
Toxoplasmosis Testing Market Diagnostics Sales
by Major Supplier
Japan
Trichomonas Testing Market Diagnostics Sales
by Major Supplier
Japan
Tuberculosis Testing Market Diagnostics Sales
by Major Supplier

2018 Global Yersinia Testing Market: US, Europe, Japan--Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition,

USD 4350View Report

2018 Global Vibrio Testing Market: US, Europe, Japan--Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

The report presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Vibrio definition,

USD 4350View Report

2018 Japan Hepatitis Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Complete report $3,900.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition,

USD 3900View Report

2018 Japan HIV/AIDS Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Complete report $2,300.  DataPack (test volumes, sales forecasts, supplier shares) $1,500. This report presents detailed analyses of the AIDS diagnostics market in Japan. The report provides test volume and sales

USD 2300View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 8800
  • Global Licence    USD 19400
$ 8800

Reports Details

Published Date : Jun 2018
No. of Pages :976
Country :Japan
Category :Healthcare
Publisher :VPGMarketResearch.com
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube